Items per page
Sort by

Send to:

Choose Destination

Links from Books

Items: 7


Humanized radioiodinated minibody for imaging of prostate stem cell antigen-expressing tumors.

Leyton JV, Olafsen T, Lepin EJ, Hahm S, Bauer KB, Reiter RE, Wu AM.

Clin Cancer Res. 2008 Nov 15;14(22):7488-96. doi: 10.1158/1078-0432.CCR-07-5093.


Targeting, imaging, and therapy using a humanized antiprostate stem cell antigen (PSCA) antibody.

Olafsen T, Gu Z, Sherman MA, Leyton JV, Witkosky ME, Shively JE, Raubitschek AA, Morrison SL, Wu AM, Reiter RE.

J Immunother. 2007 May-Jun;30(4):396-405.


Prostate stem cell antigen is overexpressed in prostate cancer metastases.

Lam JS, Yamashiro J, Shintaku IP, Vessella RL, Jenkins RB, Horvath S, Said JW, Reiter RE.

Clin Cancer Res. 2005 Apr 1;11(7):2591-6.


Prostate stem cell antigen is overexpressed in human transitional cell carcinoma.

Amara N, Palapattu GS, Schrage M, Gu Z, Thomas GV, Dorey F, Said J, Reiter RE.

Cancer Res. 2001 Jun 15;61(12):4660-5.


Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer.

Gu Z, Thomas G, Yamashiro J, Shintaku IP, Dorey F, Raitano A, Witte ON, Said JW, Loda M, Reiter RE.

Oncogene. 2000 Mar 2;19(10):1288-96.


Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer.

Reiter RE, Gu Z, Watabe T, Thomas G, Szigeti K, Davis E, Wahl M, Nisitani S, Yamashiro J, Le Beau MM, Loda M, Witte ON.

Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1735-40.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk